Neuland Laboratories Limited

NSE:NEULANDLAB.NS

12014 (INR) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12017 Q42017 Q32017 Q22017 Q12009 Q42009 Q32009 Q22009 Q12008 Q32008 Q2
Revenue 3,283.63,980.3183,108.4384,396.0173,850.0973,928.2834,177.4863,629.9393,767.7312,692.52,937.0552,211.6992,281.32,364.6982,578.4762,008.8672,447.0472,453.9182,413.9282,054.2381,916.4192,038.4371,862.1771,810.0751,732.7361,714.7951,687.4081,539.5751,475.0771,413.6441,444.2891,450.067855.811833.927792.33585.152575.177492.375
Cost of Revenue 1,719.9042,057.2451,597.5573,024.5521,800.1991,785.9151,915.8051,836.0482,086.5891,394.3451,462.0231,194.8961,499.7071,399.9421,467.1941,168.1781,981.4051,426.5691,478.9941,245.6771,144.251,295.9891,139.8091,197.8991,113.4861,127.5071,141.2371,049.333825.99749.544909.049880.123402.786786.336726.673539.102451.355473.098
Gross Profit 1,563.6961,923.0731,510.8811,371.4652,049.8982,142.3682,261.6811,793.8911,681.1421,298.1551,475.0321,016.803781.593964.7561,111.282840.689465.6421,027.349934.934808.561772.169742.448722.368612.176619.25587.288546.171490.242649.087664.1535.24569.944453.02547.59165.65746.05123.82219.277
Gross Profit Ratio 0.4760.4830.4860.3120.5320.5450.5410.4940.4460.4820.5020.460.3430.4080.4310.4180.190.4190.3870.3940.4030.3640.3880.3380.3570.3420.3240.3180.440.470.3710.3930.5290.0570.0830.0790.2150.039
Reseach & Development Expenses 0000349.917000277.576000277.230000000174.114000000049.88469.63800000000
General & Administrative Expenses 0000000000000000000000000000-60.687235.948155.922161.269000000
Selling & Marketing Expenses 0000000000000000000000000000227.43862.11471.432111.326000000
SG&A 388.38200300.666355.844-423.885-1,229.7950503.683000446.8280209.5660321.927182.329188.526123.806336.75000385.967000166.751298.062227.354272.595000056.7580
Other Expenses 1,221.8761,220.0931,049.348001,081.1512,261.6811,793.89101,298.1551,475.0321,016.8030964.756593.199840.6890483.103430.488434.9390742.448722.368612.1760587.288546.171490.2420500.755101.19392.995445.224-15.6160.5650.520.2450
Operating Expenses 1,221.8761,220.0931,049.348300.666355.844657.2661,031.8861,793.891781.2591,298.1551,475.0321,016.803490.067964.756802.765840.689321.927665.432619.014558.745480.894742.448722.368612.176374.352587.288546.171490.242364.198868.455328.547365.59445.224-15.6160.5650.5257.0030
Operating Income 341.82702.98461.5331,070.799904.541,061.2171,260.273833.3441,216.642407.469561.249158.054317.207196.576308.517138.602168.681361.917315.92249.816254.899203.419166.674111.095174.81186.07188.83734.755323.167-204.355206.693204.3557.80163.20765.09245.5366.81919.277
Operating Income Ratio 0.1040.1770.1480.2440.2350.270.3020.230.3230.1510.1910.0710.1390.0830.120.0690.0690.1470.1310.1220.1330.10.090.0610.1010.050.0530.0230.219-0.1450.1430.1410.0090.0760.0820.0780.1160.039
Total Other Income Expenses Net 51.176574.66932.693227.62117.48-16.407-44.333-1.749-115.006-18.118-29.363-23.463-74.454-14.217-32.736-17.8775.22-42.44-29.064-46.714-82.919-46.701-42.132-35.11-93.106-25.946-34.353-27.699-48.31301.539-52.796-54.44766.264-37.815-34.89-31.849-31.998-6.899
Income Before Tax 392.9961,277.649494.2261,298.42922.021,044.811,215.94831.5951,101.636389.351531.886134.591242.753182.359275.781120.732243.901319.477286.856203.102171.98156.718124.54275.98581.70560.12554.4847.056274.85897.185153.897149.90874.06525.39230.20213.68134.82112.378
Income Before Tax Ratio 0.120.3210.1590.2950.2390.2660.2910.2290.2920.1450.1810.0610.1060.0770.1070.060.10.130.1190.0990.090.0770.0670.0420.0470.0350.0320.0050.1860.0690.1070.1030.0870.030.0380.0230.0610.025
Income Tax Expense 114.937261.781165.799319.693246.401230.908323.462212.805256.19783.869147.28934.93324.94553.00372.0733.38770.97552.12572.45651.472264.93745.61437.65518.91415.39913.2098.9741.37570.72733.6750.0149.408-7.86721.4993.55.162-0.05
Net Income 278.0591,015.868328.427978.727675.619813.902892.478618.79845.439305.482384.59799.658217.807129.356203.71187.345172.926267.352214.4151.63-92.957111.10486.88757.07166.30646.91645.515.681204.13163.515103.887100.581.95518.3928.70310.18140.47112.428
Net Income Ratio 0.0850.2550.1060.2230.1750.2070.2140.170.2240.1130.1310.0450.0950.0550.0790.0430.0710.1090.0890.074-0.0490.0550.0470.0320.0380.0270.0270.0040.1380.0450.0720.0690.0960.0220.0110.0170.070.025
EPS 21.6779.1825.676.2852.6663.4469.5648.2365.923.8129.977.7716.9810.0815.886.8113.4820.8416.7111.82-7.258.666.774.455.173.663.550.4422.987.1511.6911.3112.342.821.331.566.191.9
EPS Diluted 21.6779.1825.676.2852.6663.4469.5648.2365.923.8129.977.7716.9710.0815.886.8113.4820.8416.7111.82-7.248.666.774.455.173.663.550.4422.987.1511.6911.3112.342.821.331.566.191.9
EBITDA 585.3821,462.819665.6021,487.9241,093.5061,233.6611,405.35989.5911,231.411550.163695.359291.165355.381343.325431.207277.449340.321467.954414.675345.414264.732291.825255.189191.812140.568163.657154.392102.499369.901188.687245.259242.92135.1975.37380.47757.53979.41545.947
EBITDA Ratio 0.1780.3680.2140.3380.2840.3140.3360.2730.3270.2040.2370.1320.1560.1450.1670.1380.1390.1910.1720.1680.1380.1430.1370.1060.0810.0950.0910.0670.2510.1330.170.1680.1580.090.1020.0980.1380.093